Article
Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
Molecular microbiology - 1 May 2004
Hong Hee-Jeon, Hutchings Matthew I, Neu John M, Wright Gerard D, Paget Mark S B, Buttner Mark J
Abstract excerpt
Vancomycin is the front-line therapy for treating problematic infections caused by methicillin-resistant Staphylococcus aureus (MRSA), and the spread of vancomycin resistance is an acute problem. Vancomycin blocks cross-linking between peptidoglycan intermediates by binding to the D-Ala-D-Ala termini of bacterial cell wall precursors, which are the substrate of transglycosylase/transpeptidase. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
